Home › Markets › Health Care › CTSO

Cytosorbents Corporation (CTSO)

CTSO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.46
-3.62% on the day
Market cap
$10.9M
Nano cap
Revenue · 2025
$37.1M
No prior year to compare
Net income · 2025
-$8.2M
-22.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1175151/000110465926036451/0001104659-26-036451-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.

Profile

FieldValue
TickerCTSO on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001175151
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$37.1M
Net income-$8.2M
Operating income-$14.7M
Net margin-22.1%
Operating margin-39.8%
Revenue growthNo prior-year revenue to compare
Cash$6.2M
Total assets$44.2M
P/E (computed)Net income was not positive
P/S (computed)0.3×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-12-09
Latest annual report10-K/A2026-04-15
Latest quarterly / interim10-Q2026-08-06
Latest current report
FORM 8-K
8-K2026-09-23
Latest proxyDEFA14A2026-06-25

Source: SEC EDGAR submissions feed, 977 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
NMTCNeuroOne Medical Technologies Corporation$1.10+2.33%$10.0M
PLSMPulsenmore Ltd.$1.90+4.40%$12.4M
CNSYCerenome Inc. Common Stock$1.74-3.87%$13.2M
AEMDAethlon Medical Inc.$5.58-4.78%$9.0M
FEMYFemasys Inc.$1.76+0.57%$14.7M
SINTSiNtx Technologies Inc.$2.07-2.82%$15.6M
CODXCo-Diagnostics Inc.$1.06-14.80%$7.5M
RVPRetractable Technologies Inc.$0.6100-6.15%$18.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier